Literature DB >> 15825409

Mechanism of silver sulfadiazine action on burn wound infections.

C L Fox, S M Modak.   

Abstract

The role of silver and sulfadiazine in the mechanism of action of silver sulfadiazine on burn wound infections was investigated. Silver, but not sulfadiazine, was bound by bacteria. Sulfadiazine did not act as an antibacterial agent in low concentrations, but exhibited specific synergism in combination with subinhibitory levels of silver sulfadiazine. The efficacy of silver sulfadiazine is thought to result from its slow and steady reactions with serum and other sodium chloride-containing body fluids, which permits the slow and sustained delivery of silver ions into the wound environs. In this circumstance, a relatively minute amount of sulfadiazine appears active.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 15825409      PMCID: PMC429018          DOI: 10.1128/AAC.5.6.582

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

2.  Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim.

Authors:  E J Lowbury; D M Jackson; C R Ricketts; B Davis
Journal:  Injury       Date:  1971-07       Impact factor: 2.586

3.  Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns.

Authors:  C L Fox
Journal:  Arch Surg       Date:  1968-02

4.  Control of pseudomonas infections in burns with silver sulfadiazine.

Authors:  J N Withers
Journal:  Hawaii Med J       Date:  1970 Mar-Apr

5.  Control of pseudomonas infection in burns by silver sulfadiazine.

Authors:  C L Fox; B W Rappole; W Stanford
Journal:  Surg Gynecol Obstet       Date:  1969-05

6.  Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns.

Authors:  W Stanford; B W Rappole; C L Fox
Journal:  J Trauma       Date:  1969-05

7.  Burns and the use of silver sulphadiazine.

Authors:  I A McDougall
Journal:  Aust N Z J Surg       Date:  1972-11

8.  Mechanism of prophylaxis by silver compounds against infection of burns.

Authors:  C R Ricketts; E J Lowbury; J C Lawrence; M Hall; M D Wilkins
Journal:  Br Med J       Date:  1970-05-23

9.  Virulence of Pseudomonas infection in burned rats and mice. Comparative efficacy of silver sulfadiazine and mafenide.

Authors:  C L Fox; A C Sampath; J W Stanford
Journal:  Arch Surg       Date:  1970-10

10.  Silver sulfadiazine: in vitro antibacterial activity.

Authors:  H S Carr; T J Wlodkowski; H S Rosenkranz
Journal:  Antimicrob Agents Chemother       Date:  1973-11       Impact factor: 5.191

View more
  41 in total

1.  Evaluation of the medicinal use of clay minerals as antibacterial agents.

Authors:  Lynda B Williams; Shelley E Haydel
Journal:  Int Geol Rev       Date:  2010-07-01       Impact factor: 3.958

2.  Susceptibility of multidrug-resistant isolates of Klebsiella pneumoniae to silver nitrate.

Authors:  N Kapoor; S Chhibber; D V Vadehra
Journal:  Folia Microbiol (Praha)       Date:  1989       Impact factor: 2.099

3.  Contribution of silver ion resistance to the pathogenicity of Pseudomonas aeruginosa with special reference to burn wound sepsis.

Authors:  R Vasishta; M Saxena; S Chhibber
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

4.  Development of novel chitin/nanosilver composite scaffolds for wound dressing applications.

Authors:  K Madhumathi; P T Sudheesh Kumar; S Abhilash; V Sreeja; H Tamura; K Manzoor; S V Nair; R Jayakumar
Journal:  J Mater Sci Mater Med       Date:  2009-10-03       Impact factor: 3.896

5.  Creation and Evaluation of New Porcine Model for Investigation of Treatments of Surgical Site Infection.

Authors:  Mahsa Mohiti-Asli; Marije Risselada; Megan Jacob; Behnam Pourdeyhimi; Elizabeth G Loboa
Journal:  Tissue Eng Part C Methods       Date:  2017-09-19       Impact factor: 3.056

6.  Heavy metal resistance in clinical isolates of Pseudomonas aeruginosa.

Authors:  R Vasishta; S Chhibber; M Saxena
Journal:  Folia Microbiol (Praha)       Date:  1989       Impact factor: 2.099

7.  Silver toxicity with the use of silver-impregnated dressing and wound vacuum-assisted closure in an immunocompromised patient.

Authors:  Cabrini A Lariviere; Adam B Goldin; Jeffrey Avansino
Journal:  J Am Col Certif Wound Spec       Date:  2011-05-27

8.  Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate.

Authors:  Yoshinobu Matsumura; Kuniaki Yoshikata; Shin-ichi Kunisaki; Tetsuaki Tsuchido
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

9.  Structural properties, cytotoxicity, and anti-inflammatory activity of silver(I) complexes with tris(p-tolyl)phosphine and 5-chloro-2-mercaptobenzothiazole.

Authors:  L Kyros; N Kourkoumelis; M Kubicki; L Male; M B Hursthouse; I I Verginadis; E Gouma; S Karkabounas; K Charalabopoulos; S K Hadjikakou
Journal:  Bioinorg Chem Appl       Date:  2010-03-29       Impact factor: 7.778

Review 10.  Use of silver in the prevention and treatment of infections: silver review.

Authors:  Amani D Politano; Kristin T Campbell; Laura H Rosenberger; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2013-02-28       Impact factor: 2.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.